Biopharma Industry Articles & Analysis
17 articles found
Introduction Good Manufacturing Practice (GMP) cell banks play a crucial role in the biopharmaceutical industry, serving as foundational repositories of cell lines used for the production of therapeutic biological products. Characterization of these cell banks is essential to ensure the safety, efficacy, and consistency of the biopharmaceuticals derived from them. This article will explore the ...
The quest for transformative cell and gene therapies has ignited a wave of innovation in biopharmaceuticals. As the industry races to unlock these treatments’ full potential, the intricacies of therapy development present unprecedented challenges. From navigating a highly regulated environment to ensuring streamlined workflows for quality products within tight deadlines, the journey is ...
Today, navigating the complex landscape of AAV manufacturing has become a focal point for professionals in the biopharma industry looking to exploit this technology in the development of breakthrough treatments. ...
In 2022, our team continued its explosive growth on the back of the many successes we’ve achieved in preformulation, formulation, target product profiles, and helping our clients advance their products into the clinic. We’ve done all these things and more – and our numbers reflect that. It was a fitting way to celebrate our 10th anniversary as one of the industry’s leading ...
The arrival of the COVID-19 pandemic has challenged the world’s health system and organization. To control and prevent this virus and others of its kind, vaccination has been adopted as an effective way to protect public health. Vaccines are chemical and biological products, which means they are sensitive to both cold and heat and must be kept in cold storage throughout the vast cold ...
Annalisa Jenkins' inspirational career spans over 25 years in the global biopharma industry – she started her career at St Barts, in London, where she trained as a cardiologist, before joining the British Royal Navy as a medical officer during the Gulf Conflict, achieving the rank of surgeon lieutenant commander during her time there. ...
There is a growing need to address the high failure rate of drug candidates as they progress through clinical trials. Altis Biosystems aims to bring its technological advances to the forefront, enabling the drug development process to more effectively translate results from preclinical experiments to late-stage clinical trials. Breaking the Conformity of Inadequate Testing Platforms The ...
Unlocking the chemistry of the remaining 99% of microorganisms, the ‘unculturable’ fraction, to obtain drug-like natural compounds could have a substantial impact on multibillion-dollar industries, including biopharma, agriculture, and consumer/cosmetic ...
Few sectors are as captive to water requirements and regulations as the biopharmaceutical industry. Water is a critical component in the manufacture of active pharmaceutical ingredients (APIs), life-saving drugs, vaccines, PPE, testing kits and many more products. To gain a clear picture, water for industrial use represents a significant part of global water demand and if nothing is done to ...
ABSTRACT Engineering controls designed to mitigate exposure and create separation between the operator and the toxic material are available in many different forms, all with their own unique advantages and risks. This article will look into various forms of containment while asking the question, is your liability assured or insured? ASSURANCE VS INSURANCE Assurance is defined as a positive ...
Diaphragm valves are developed from plastic or metal. It is essentially based on the producer. These valves have two or more ports, and they are typically used in subsistence, refreshment, pharmaceutical and preparation activities. Stomach valves can reach a pristine close much after many years of neglect. The floodgates grew in fame during the previous decade. An expansive number of commercial ...
“A lot of our customers in the biopharma and medical-device industries had already started to use Amazon for GxP and non-GxP workloads,” says Kratz. ...
Has LC-MS Become a Generally Accepted Tool for Complementing Immunoassay-based HCP Analysis? My colleague Catalin Doneanu and I just returned from Lisbon, Portugal, where we attended the BEBPA Conference on Host Cell Protein (HCP) analysis. Along with the other 120 attendees, we participated in open and thoughtful discussions on the best practices for HCP analysis using conventional ...
In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not ...
This article estimates the production technical efficiency of pharmaceutical companies and biotechnology companies under heterogeneous technologies. We employ metafrontier analysis to estimate the production metafrontier technical efficiency during the period 1989–2007. When using traditional stochastic frontier analysis, the results show that the technical efficiency of the biotechnology ...
The commercial use of embryonic or adult stem cells is still in its infancy. Most young firms concentrated on the generation and storage of stem cells, the development of tissues and related equipment. But the perspectives of therapeutic use of stem cells attract a lot of political and commercial attention to possible new strategic markets opening up new fields besides incumbent ...
Animal experimentation has provoked debate since its establishment, in the modern sense. Recent years have seen a culmination of the debate. Animal rights campaigners have used direct action in order to stop experimentation, and both the industry and the government have replied through toughening security and implementing legislative changes. The main issue is ethics: can we, and on what grounds, ...